サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：配合剤診断市場：製品タイプ別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2023年～2030年
市場調査レポート
商品コード
1397092

配合剤診断市場：製品タイプ別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2023年～2030年

Combination Drugs Diagnostic Market, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 303 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円
配合剤診断市場：製品タイプ別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2023年～2030年
出版日: 2023年12月01日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

配合剤診断市場 - 市場力学

市場成長の促進力は、高齢者の増加と診断技術の進歩にあると予測

高齢化社会にはより包括的なヘルスケアソリューションが必要であり、これに対処するアプローチの1つが診断機能を組み込んだ配合剤です。これらの薬剤は、高齢者の健康管理に総合的なアプローチを提供します。世界保健機関は、2030年までに世界の6人に1人が60歳以上になると予測しており、その結果、60歳以上の人口は2020年の10億人から14億人に増加することになります。診断学の進歩により、疾病や病態の早期発見が可能となり、タイムリーな介入や、疾病の初期段階での配合剤療法の開始が可能となります。しかし、COVID-19の流行もこの上昇に寄与しており、遠隔診察予約、患者モニタリング、遠隔医療サービスの採用が進んでいます。現在30億人を突破し、2023年には40億人を超えると予測されるスマートフォンユーザーの増加が、ヘルスケアアプリの人気をさらに押し上げています。さらに、医療技術の統計によると、現在アメリカ人の5人に1人がフィットネストラッカーやスマートウォッチを利用しており、この数は2025年までに20％増加すると予想されています。医療技術と医薬品開発におけるこのような進歩は、革新的な配合剤を生み出す機会を提供しています。しかし、診断薬成分を含む配合剤に対する償還政策の確立が課題となる可能性があります。

配合剤診断市場 - 主要洞察

弊社のリサーチアナリストの分析によると、世界の配合剤診断市場は予測期間（2023年～2030年）に約9.2%のCAGRで毎年成長すると推定されます。

可処分所得の増加と配合剤に対する意識の高まりにより、配合剤診断分野は大幅な成長が見込まれます。

市場セグメンテーションに基づくと、抗菌カテーテルが2022年に最大の市場シェアを示すと予測されます。

用途別では、感染症が2022年の主要タイプでした。

地域別では、北米が2022年に収益を上げる主要市場でした。

配合剤診断市場 - セグメンテーション分析：

配合剤診断の世界市場は、製品タイプ、用途、地域によって区分されます。

市場は製品タイプにより3つに分類されます：超音波、抗菌カテーテル、心血管カテーテル、泌尿器カテーテル、酸素測定カテーテル、骨移植代替物、ポルフィマーナトリウム＆ステロイド、溶出性電極です。現在、市場は抗菌カテーテルが支配的です。しかし、診断薬、配合剤療法、抗菌カテーテルを含む包括的なソリューションを提供する企業は、ヘルスケアにおける感染予防の複雑な問題に取り組み、潜在的なチャンスをつかむことができるかもしれません。

市場は用途別に2つのカテゴリーに分類されます：感染症、心血管疾患、精神疾患、呼吸器疾患です。市場は感染症に大きく影響されます。感染症の領域では、医薬品と診断薬の融合が重要な要素となっています。この包括的なアプローチにより、病原体や個々の患者の反応の特徴を考慮した、より正確で焦点を絞った治療計画が容易になります。

配合剤診断市場 - 地理的洞察

地域的には、配合剤診断市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカなど様々な地域に広がっています。これらの地域は、事業活動に関与する国々に基づいてさらに分類されます。配合剤診断市場の成長は、主に研究開発（R&D）事業への投資の増加により、北米が支配すると予想されます。北米、特に米国は、製薬およびバイオテクノロジー研究開発の世界の中心地として認識されています。研究開発事業への多額の投資は、診断薬成分を組み込んだ革新的な配合薬の開発に貢献しています。全米科学財団内の全米科学技術統計センター（NCSES）によると、米国の研究開発活動への総支出は2020年に7,170億米ドルに達しました。欧州は、がん、心臓病、糖尿病などの慢性疾患の増加により、第2位の市場シェアを占めています。

配合剤診断市場 - 競合情勢：

配合剤診断市場の競争環境はダイナミックであり、多数の企業が配合剤治療の指針となる診断ツールの開発と商業化に貢献しています。各メーカーは、配合剤物療法をサポートする診断薬の開発に積極的に取り組んでいます。臨床現場で導入されつつある新世代の標的療法のかなりの部分は、コンパニオン診断薬として知られており、その療法の適応に必要不可欠な検査を患者が受けることを要求しています。さらに、補完的診断と呼ばれる、治療方針の決定をサポートする検査もありますが、処方の前には必須ではありません。このような製薬会社の新薬開発方法の変化により、薬事承認を求める薬剤と診断薬の組み合わせの数が大幅に増加しています。個々の患者の特性に合わせて治療方針を決定する個別化医療への動向の高まりは、配合剤診断市場の大きな促進力となっています。特に診断技術と画像診断における継続的な技術進歩は、競合情勢の形成に重要な役割を果たしています。

目次

第1章 配合剤診断市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 配合剤診断の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 配合剤診断産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 配合剤診断市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 配合剤診断市場情勢

  • 配合剤診断市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 配合剤診断市場：製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • 超音波
    • 抗菌カテーテル
    • 心臓血管カテーテル
    • 泌尿器科用カテーテル
    • 酸素濃度計カテーテル
    • 骨移植片代替品
    • ポルフィマーナトリウムとステロイド
    • 溶出電極

第8章 配合剤診断市場：用途別

  • 概要
    • 用途別のセグメントシェア分析
    • 感染症
    • 心血管疾患
    • 精神障害
    • 呼吸器疾患

第9章 配合剤診断市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋地域（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析：配合剤診断業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Abbott Laboratories
    • Roche
    • Novartis International AG
    • GlaxoSmithKline plc.
    • Pfizer Inc.
    • Sanofi
    • Bristol-Myers Squibb Company
    • Johnson &Johnson
    • Eli Lilly and Company
    • Gilead Sciences, Inc.

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Combination Drugs Diagnostic Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Combination Drugs Diagnostic Market, by Product Type 2018-2030 (USD Million)
  • TABLE Combination Drugs Diagnostic Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Combination Drugs Diagnostic Market, by Application 2018-2030 (USD Million)
  • TABLE Combination Drugs Diagnostic Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Combination Drugs Diagnostic Market, by Region 2018-2030 (USD Million)
  • TABLE North America Combination Drugs Diagnostic Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Combination Drugs Diagnostic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Combination Drugs Diagnostic Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Combination Drugs Diagnostic Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Combination Drugs Diagnostic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Combination Drugs Diagnostic Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Combination Drugs Diagnostic Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Combination Drugs Diagnostic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Combination Drugs Diagnostic Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Combination Drugs Diagnostic Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Combination Drugs Diagnostic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Combination Drugs Diagnostic Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Combination Drugs Diagnostic Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Combination Drugs Diagnostic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Combination Drugs Diagnostic Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Combination Drugs Diagnostic Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Combination Drugs Diagnostic Market share and leading players, 2022
  • FIGURE Europe Combination Drugs Diagnostic Market share and leading players, 2022
  • FIGURE Asia Pacific Combination Drugs Diagnostic Market share and leading players, 2022
  • FIGURE Latin America Combination Drugs Diagnostic Market share and leading players, 2022
  • FIGURE Middle East and Africa Combination Drugs Diagnostic Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Combination Drugs Diagnostic Market share analysis by country, 2022
  • FIGURE Germany Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Combination Drugs Diagnostic Market share analysis by country, 2022
  • FIGURE India Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Combination Drugs Diagnostic Market share analysis by country, 2022
  • FIGURE Brazil Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Combination Drugs Diagnostic Market share analysis by country, 2022
  • FIGURE Saudi Arabia Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1863

REPORT HIGHLIGHT

The combination medications and diagnostic tools plays a crucial role in modern healthcare, particularly in the realm of personalized medicine and targeted therapies. A combination product refers to a therapeutic or diagnostic product that combines drugs, medical devices, and/or biological products. Such products typically involve at least two of these categories and sometimes encompass all three. Common examples include traditional drug-device combinations, such as a syringe pre-filled with medication, as well as co-packaged or kitted products, like a first-aid kit containing bandages and pain-relieving medications. In the healthcare field, diagnostics pertain to the identification of the nature and cause of a disease or condition. Diagnostic tools encompass various techniques, including imaging, laboratory tests, and other medical assessments.

Combination Drugs Diagnostic Market- Market Dynamics

The market growth is anticipated to be driven by the increasing number of elderly individuals and advancements in diagnostic techniques.

Aging populations necessitate more comprehensive healthcare solutions, and one approach to address this is through combination drugs that incorporate diagnostic capabilities. These drugs offer a holistic approach to managing the health of elderly individuals. The World Health Organization predicts that by 2030, 1 in 6 people worldwide will be aged 60 years or over, resulting in an increase in the population aged 60 years and over from 1 billion in 2020 to 1.4 billion. The advancement of diagnostics allows for the early detection of diseases and conditions, enabling timely intervention and the initiation of combination drug therapies at the earliest stages of illnesses. However, the COVID-19 pandemic has also contributed to this rise, with the adoption of remote doctor's appointments, patient monitoring, and telehealth services. The increasing number of smartphone users, which has surpassed 3 billion today and is projected to exceed 4 billion by 2023, has further boosted the popularity of healthcare apps. Additionally, medical technology statistics indicate that 1 in 5 Americans currently utilize fitness trackers or smartwatches, a number expected to grow by 20% by 2025. These advancements in medical technology and drug development present opportunities for the creation of innovative combination drugs. However, establishing reimbursement policies for combination drugs that include diagnostic components can pose a challenge.

Combination Drugs Diagnostic Market- Key Insights

  • As per the analysis shared by our research analyst, the global Combination Drugs Diagnostic market is estimated to grow annually at a CAGR of around 9.2% over the forecast period (2023-2030)
  • The Combination Drugs Diagnostic sector is expected to experience substantial growth as a result of an increase in disposable income and greater awareness of combination drugs.
  • Based on product type segmentation, Antimicrobial catheters were predicted to show maximum market share in the year 2022
  • Based on Application segmentation, Infectious Diseases was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Combination Drugs Diagnostic Market- Segmentation Analysis:

The Global Combination Drugs Diagnostic Market is segmented on the basis of Product Type, Application, and Region.

The market is divided into three categories based on product type: Ultrasound, Antimicrobial catheters, Cardiovascular catheters, urological catheters, Oximetry catheters, Bone graft substitutes, Porfimer sodium & steroid and Eluting electrodes. The market is currently dominated by antimicrobial catheters. However, companies that provide comprehensive solutions, including diagnostics, combination drug therapies, and antimicrobial catheters, may be able to tackle the intricate issues of infection prevention in healthcare and seize potential opportunities.

The market is divided into two categories based on application: Infectious Diseases, Cardiovascular Diseases, Psychiatric Disorders, and Respiratory Disorders. The market is largely influenced by Infectious Diseases. The amalgamation of drugs and diagnostics is proving to be a crucial factor in the realm of infectious diseases. This comprehensive approach facilitates more accurate and focused treatment plans, taking into account the unique features of pathogens and individual patient reactions.

Combination Drugs Diagnostic Market- Geographical Insights

Geographically, the market for Combination Drugs Diagnostics is spread across various regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further categorized based on the countries involved in business activities. The growth of the Combination Drugs Diagnostic market is expected to be dominated by North America, primarily due to the increasing investments in research and development (R&D) operations. North America, especially the United States, is recognized as a global center for pharmaceutical and biotechnology R&D. The substantial investments in R&D operations contribute to the development of innovative combination drugs that incorporate diagnostic components. According to the National Center for Science and Engineering Statistics (NCSES) within the National Science Foundation, the total expenditure on R&D activities in the United States reached USD 717.0 billion in 2020. Europe holds the second-largest market share, driven by the rising prevalence of chronic diseases such as cancer, heart disease, and diabetes.

Combination Drugs Diagnostic Market- Competitive Landscape:

The landscape of the market for combination drug diagnostics has been dynamic, with numerous companies contributing to the advancement and commercialization of diagnostic tools for guiding combination drug therapies. The manufacturers are actively involved in developing diagnostics that support combination drug therapies. A significant portion of the new generation of targeted therapies being introduced in clinical settings require patients to undergo essential tests that are necessary for the therapy's indication, known as companion diagnostics. Additionally, there are tests known as complementary diagnostics that support treatment decisions but are not essential prior to prescription. This shift in the way pharmaceutical companies develop new medicines has led to a significant increase in the number of drug-diagnostic combinations seeking regulatory approval. The growing trend towards personalized medicine, where treatment decisions are tailored to individual patient characteristics, is a major driving force in the combination drugs diagnostic market. Ongoing technological advancements, particularly in diagnostic technologies and imaging, play a crucial role in shaping the competitive landscape.

Recent Developments:

Roche's Columvi has been granted FDA approval as a third-line treatment for diffuse large B-cell lymphoma, a type of blood cancer. This new drug will now compete with AbbVie's Epkinly, which was recently approved for the same condition. The approval of Roche's new drug provides patients with another therapeutic option.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL COMBINATION DRUGS DIAGNOSTIC MARKET KEY PLAYERS

  • Abbott Laboratories
  • Roche
  • Novartis International AG
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • Sanofi
  • Bristol-Myers Squibb Company
  • Johnson & Johnson
  • Eli Lilly and Company
  • Gilead Sciences, Inc.

GLOBAL COMBINATION DRUGS DIAGNOSTIC MARKET, BY PRODUCT TYPE

  • Ultrasound
  • Antimicrobial catheters
  • Cardiovascular catheters
  • Urological catheters
  • Oximetry catheters
  • Bone graft substitutes
  • Porfimer sodium & steroid
  • Eluting electrodes

GLOBAL COMBINATION DRUGS DIAGNOSTIC MARKET, BY APPLICATION

  • Infectious Diseases
  • Cardiovascular Diseases
  • Psychiatric Disorders
  • Respiratory Disorders

GLOBAL COMBINATION DRUGS DIAGNOSTIC MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Combination Drugs Diagnostic Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Combination Drugs Diagnostic Market Snippet by Product Type
    • 2.1.2. Combination Drugs Diagnostic Market Snippet by Application
    • 2.1.3. Combination Drugs Diagnostic Market Snippet by Country
    • 2.1.4. Combination Drugs Diagnostic Market Snippet by Region
  • 2.2. Competitive Insights

3. Combination Drugs Diagnostic Key Market Trends

  • 3.1. Combination Drugs Diagnostic Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Combination Drugs Diagnostic Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Combination Drugs Diagnostic Market Opportunities
  • 3.4. Combination Drugs Diagnostic Market Future Trends

4. Combination Drugs Diagnostic Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Combination Drugs Diagnostic Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Combination Drugs Diagnostic Market Landscape

  • 6.1. Combination Drugs Diagnostic Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Combination Drugs Diagnostic Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Ultrasound
    • 7.1.3. Antimicrobial catheters
    • 7.1.4. Cardiovascular catheters
    • 7.1.5. Urological catheters
    • 7.1.6. Oximetry catheters
    • 7.1.7. Bone graft substitutes
    • 7.1.8. Porfimer sodium & steroid
    • 7.1.9. Eluting electrodes

8. Combination Drugs Diagnostic Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Infectious Diseases
    • 8.1.3. Cardiovascular Diseases
    • 8.1.4. Psychiatric Disorders
    • 8.1.5. Respiratory Disorders

9. Combination Drugs Diagnostic Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Combination Drugs Diagnostic Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Combination Drugs Diagnostic Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Combination Drugs Diagnostic Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Combination Drugs Diagnostic Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Combination Drugs Diagnostic Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Combination Drugs Diagnostic Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Abbott Laboratories
    • 10.2.2. Roche
    • 10.2.3. Novartis International AG
    • 10.2.4. GlaxoSmithKline plc.
    • 10.2.5. Pfizer Inc.
    • 10.2.6. Sanofi
    • 10.2.7. Bristol-Myers Squibb Company
    • 10.2.8. Johnson & Johnson
    • 10.2.9. Eli Lilly and Company
    • 10.2.10. Gilead Sciences, Inc.

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us